1769P Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior anti–colony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study
医学
肿瘤科
内科学
临床研究阶段
临床试验
作者
C. Serrano,Jean‐Yves Blay,P. Rutkowski,Hans Gelderblom,S. Stacchiotti,A. Falcon Gonzalez,Janak Desai,A. Le Cesne,Virginia Ferraresi,E. Palmerini,Breelyn A. Wilky,Andrew J. Wagner,Nicholas M. Bernthal,Michiel A. J. van de Sande,Supraja Narasimhan,B. Harrow,Manu Sharma,R. Ruiz-Soto,M.L. Sherman,W.D. Tap